Sharon Terry on Changes in Drug Discovery, Diagnostics, and the Treatment of Patients

Harry talks with Sharon Terry, president and CEO of Genetic Alliance, about the way drug discovery, diagnostics, and the treatment of patients are changing.

Harry is well known for achievements in life sciences, healthcare, diagnostics, healthcare IT and the convergence of these areas. He is a sought-after speaker, frequently quoted in the media, and regularly asked to assess, influence, and be part of innovative concepts and trends. He holds four US patents in telecommunications, and has others pending.